<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Adia Nutrition Inc — News on 6ix</title>
<link>https://6ix.com/company/adia-nutrition-inc</link>
<description>Latest news and press releases for Adia Nutrition Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 22 Apr 2026 12:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/adia-nutrition-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835429778dffbe2df0e1594.webp</url>
<title>Adia Nutrition Inc</title>
<link>https://6ix.com/company/adia-nutrition-inc</link>
</image>
<item>
<title>Adia Nutrition, Inc. Looking to Acquire Larger Property to Expand Flagship Clinic in Winter Park, Reports Strong Operational Momentum in Q1 2026 and Provides Optimistic Outlook for Remainder of the Year</title>
<link>https://6ix.com/company/adia-nutrition-inc/news/adia-nutrition-inc-looking-to-acquire-larger-property-to-expand-flagship-clinic-in-winter-park-reports-strong-operational-momentum-in-q1-2026-and-provides-optimistic-outlook-for-remainder-of-the-year</link>
<guid isPermaLink="true">https://6ix.com/company/adia-nutrition-inc/news/adia-nutrition-inc-looking-to-acquire-larger-property-to-expand-flagship-clinic-in-winter-park-reports-strong-operational-momentum-in-q1-2026-and-provides-optimistic-outlook-for-remainder-of-the-year</guid>
<pubDate>Wed, 22 Apr 2026 12:00:00 GMT</pubDate>
<description>Winter Park, Florida--(Newsfile Corp. - April 22, 2026) - Adia Nutrition, Inc. (OTCQB: ADIA), a leader in regenerative medicine, stem cell therapies, and biologic products through its Adia Med clinics and Adia Labs division, today announced that it is actively looking to acquire a larger property to expand its flagship Adia Med clinic in Winter Park, Florida. This strategic initiative aims to significantly increase the clinic's size and capacity, enabling expanded patient access to advanced...</description>
</item>
<item>
<title>Adia Nutrition, Inc. Announces Corporate Name Change to Adia Med, Inc. to Better Align with Its Regenerative Medicine and Biologics Business Model</title>
<link>https://6ix.com/company/adia-nutrition-inc/news/adia-nutrition-inc-announces-corporate-name-change-to-adia-med-inc-to-better-align-with-its-regenerative-medicine-and-biologics-business-model</link>
<guid isPermaLink="true">https://6ix.com/company/adia-nutrition-inc/news/adia-nutrition-inc-announces-corporate-name-change-to-adia-med-inc-to-better-align-with-its-regenerative-medicine-and-biologics-business-model</guid>
<pubDate>Wed, 15 Apr 2026 12:30:00 GMT</pubDate>
<description>Adia Nutrition, Inc. Announces Corporate Name Change to Adia Med, Inc. to Better Align with Its Regenerative Medicine and Biologics Business Model.</description>
</item>
<item>
<title>Adia Nutrition Strikes Major Partnership with Leading Atlanta Clinic to Launch Groundbreaking Autism Clinical Study</title>
<link>https://6ix.com/company/adia-nutrition-inc/news/adia-nutrition-strikes-major-partnership-with-leading-atlanta-clinic-to-launch-groundbreaking-autism-clinical-study</link>
<guid isPermaLink="true">https://6ix.com/company/adia-nutrition-inc/news/adia-nutrition-strikes-major-partnership-with-leading-atlanta-clinic-to-launch-groundbreaking-autism-clinical-study</guid>
<pubDate>Wed, 08 Apr 2026 12:30:00 GMT</pubDate>
<description>Adia Nutrition Strikes Major Partnership with Leading Atlanta Clinic to Launch Groundbreaking Autism Clinical Study.</description>
</item>
<item>
<title>Adia Nutrition, Inc. Reports Strong Revenue Growth in 2025 Annual Report, Highlighting Transition to Regenerative Medicine and Full SEC Reporting Status</title>
<link>https://6ix.com/company/adia-nutrition-inc/news/adia-nutrition-inc-reports-strong-revenue-growth-in-2025-annual-report-highlighting-transition-to-regenerative-medicine-and-full-sec-reporting-status-4</link>
<guid isPermaLink="true">https://6ix.com/company/adia-nutrition-inc/news/adia-nutrition-inc-reports-strong-revenue-growth-in-2025-annual-report-highlighting-transition-to-regenerative-medicine-and-full-sec-reporting-status-4</guid>
<pubDate>Wed, 01 Apr 2026 14:07:00 GMT</pubDate>
<description>Adia Nutrition, Inc. Reports Strong Revenue Growth in 2025 Annual Report, Highlighting Transition to Regenerative Medicine and Full SEC Reporting Status.</description>
</item>
<item>
<title>Tonight: Adia Nutrition and UCF CARD Host Live Zoom on Revolutionary Stem Cell Study for Autism - Strong Interest Already Building</title>
<link>https://6ix.com/company/adia-nutrition-inc/news/tonight-adia-nutrition-and-ucf-card-host-live-zoom-on-revolutionary-stem-cell-study-for-autism-strong-interest-already-building</link>
<guid isPermaLink="true">https://6ix.com/company/adia-nutrition-inc/news/tonight-adia-nutrition-and-ucf-card-host-live-zoom-on-revolutionary-stem-cell-study-for-autism-strong-interest-already-building</guid>
<pubDate>Tue, 24 Mar 2026 12:00:00 GMT</pubDate>
<description>Tonight: Adia Nutrition and UCF CARD Host Live Zoom on Revolutionary Stem Cell Study for Autism - Strong Interest Already Building.</description>
</item>
<item>
<title>Adia Med of Winter Park Appoints Amy Dalrymple, APRN, Former Mrs. Florida United States, to Lead Regenerative Aesthetics Division</title>
<link>https://6ix.com/company/adia-nutrition-inc/news/adia-med-of-winter-park-appoints-amy-dalrymple-aprn-former-mrs-florida-united-states-to-lead-regenerative-aesthetics-division</link>
<guid isPermaLink="true">https://6ix.com/company/adia-nutrition-inc/news/adia-med-of-winter-park-appoints-amy-dalrymple-aprn-former-mrs-florida-united-states-to-lead-regenerative-aesthetics-division</guid>
<pubDate>Tue, 17 Mar 2026 13:30:00 GMT</pubDate>
<description>Adia Med of Winter Park Appoints Amy Dalrymple, APRN, Former Mrs. Florida United States, to Lead Regenerative Aesthetics Division.</description>
</item>
<item>
<title>Adia Med Unveils a Fresh Facelift: New Website by ZenChange Marketing Spotlights Cutting-Edge Regenerative Medicine Studies</title>
<link>https://6ix.com/company/adia-nutrition-inc/news/adia-med-unveils-a-fresh-facelift-new-website-by-zenchange-marketing-spotlights-cutting-edge-regenerative-medicine-studies</link>
<guid isPermaLink="true">https://6ix.com/company/adia-nutrition-inc/news/adia-med-unveils-a-fresh-facelift-new-website-by-zenchange-marketing-spotlights-cutting-edge-regenerative-medicine-studies</guid>
<pubDate>Mon, 09 Mar 2026 13:38:00 GMT</pubDate>
<description>Adia Med Unveils a Fresh Facelift: New Website by ZenChange Marketing Spotlights Cutting-Edge Regenerative Medicine Studies.</description>
</item>
<item>
<title>Adia Nutrition Announces Submission of Final Revised Protocol for Lower Back Pain Study with AdiaVita</title>
<link>https://6ix.com/company/adia-nutrition-inc/news/adia-nutrition-announces-submission-of-final-revised-protocol-for-lower-back-pain-study-with-adiavita</link>
<guid isPermaLink="true">https://6ix.com/company/adia-nutrition-inc/news/adia-nutrition-announces-submission-of-final-revised-protocol-for-lower-back-pain-study-with-adiavita</guid>
<pubDate>Tue, 03 Mar 2026 15:20:00 GMT</pubDate>
<description>Adia Nutrition Announces Submission of Final Revised Protocol for Lower Back Pain Study with AdiaVita.</description>
</item>
<item>
<title>Adia Med of Winter Park Expands into Cosmetics Due to High Patient Demand - Now Interviewing Nurse Practitioners for Hair Growth and Aesthetic Procedures</title>
<link>https://6ix.com/company/adia-nutrition-inc/news/adia-med-of-winter-park-expands-into-cosmetics-due-to-high-patient-demand-now-interviewing-nurse-practitioners-for-hair-growth-and-aesthetic-procedures</link>
<guid isPermaLink="true">https://6ix.com/company/adia-nutrition-inc/news/adia-med-of-winter-park-expands-into-cosmetics-due-to-high-patient-demand-now-interviewing-nurse-practitioners-for-hair-growth-and-aesthetic-procedures</guid>
<pubDate>Tue, 24 Feb 2026 13:30:00 GMT</pubDate>
<description>Adia Med of Winter Park Expands into Cosmetics Due to High Patient Demand - Now Interviewing Nurse Practitioners for Hair Growth and Aesthetic Procedures.</description>
</item>
<item>
<title>Adia Nutrition Announces Subsidiary Adia Med's Submission of Second Clinical Study for IRB Review Targeting Lower Back Pain with AdiaVita</title>
<link>https://6ix.com/company/adia-nutrition-inc/news/adia-nutrition-announces-subsidiary-adia-meds-submission-of-second-clinical-study-for-irb-review-targeting-lower-back-pain-with-adiavita</link>
<guid isPermaLink="true">https://6ix.com/company/adia-nutrition-inc/news/adia-nutrition-announces-subsidiary-adia-meds-submission-of-second-clinical-study-for-irb-review-targeting-lower-back-pain-with-adiavita</guid>
<pubDate>Mon, 16 Feb 2026 14:00:00 GMT</pubDate>
<description>Winter Park, Florida--(Newsfile Corp. - February 16, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine and innovative therapeutic solutions, today announced that its subsidiary, Adia Med of Winter Park, LLC, has submitted its second clinical study for Institutional Review Board (IRB) review. This pivotal study will evaluate the efficacy of AdiaVita, Adia Med's proprietary umbilical cord blood-derived stem cell and exosome product, in alleviating lower back pain through</description>
</item>
<item>
<title>Adia Nutrition Inc. Plans to Initiate Four to Five New Clinical Studies in 2026, Including Expansions in Autism and New Rheumatoid Arthritis Research</title>
<link>https://6ix.com/company/adia-nutrition-inc/news/adia-nutrition-inc-plans-to-initiate-four-to-five-new-clinical-studies-in-2026-including-expansions-in-autism-and-new-rheumatoid-arthritis-research</link>
<guid isPermaLink="true">https://6ix.com/company/adia-nutrition-inc/news/adia-nutrition-inc-plans-to-initiate-four-to-five-new-clinical-studies-in-2026-including-expansions-in-autism-and-new-rheumatoid-arthritis-research</guid>
<pubDate>Mon, 09 Feb 2026 13:31:00 GMT</pubDate>
<description>Winter Park, Florida--(Newsfile Corp. - February 9, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine through its subsidiary Adia Med, today announced an ambitious expansion of its clinical research pipeline, with plans to launch four to five additional studies throughout 2026. These new initiatives will build on the company's ongoing success in regenerative therapies using Adia Vita (umbilical cord blood-derived stem cells and exosomes).Autism Study GraphicTo view an.</description>
</item>
<item>
<title>Adia Nutrition Inc. Announces Effectiveness of Form 10 Registration Statement - Now a Fully Reporting SEC Company and Advancing Toward Next Phase of Growth and NASDAQ Uplisting</title>
<link>https://6ix.com/company/adia-nutrition-inc/news/adia-nutrition-inc-announces-effectiveness-of-form-10-registration-statement-now-a-fully-reporting-sec-company-and-advancing-toward-next-phase-of-growth-and-nasdaq-uplisting</link>
<guid isPermaLink="true">https://6ix.com/company/adia-nutrition-inc/news/adia-nutrition-inc-announces-effectiveness-of-form-10-registration-statement-now-a-fully-reporting-sec-company-and-advancing-toward-next-phase-of-growth-and-nasdaq-uplisting</guid>
<pubDate>Wed, 04 Feb 2026 14:32:00 GMT</pubDate>
<description>Winter Park, Florida--(Newsfile Corp. - February 4, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine, stem cell therapies, and premium wellness solutions through its Adia Med division, today announced that its Form 10 registration statement became effective on February 3, 2026, as anticipated and in accordance with the U.S. Securities and Exchange Commission's (SEC) prior notification.The Form 10, originally filed on December 5, 2025, was not subject to further SEC...</description>
</item>
<item>
<title>Adia Nutrition Inc. Announces Dr. Brian Browning as Lead Physician for All Orthopedic Treatments and Specialties at Adia Med</title>
<link>https://6ix.com/company/adia-nutrition-inc/news/adia-nutrition-inc-announces-dr-brian-browning-as-lead-physician-for-all-orthopedic-treatments-and-specialties-at-adia-med</link>
<guid isPermaLink="true">https://6ix.com/company/adia-nutrition-inc/news/adia-nutrition-inc-announces-dr-brian-browning-as-lead-physician-for-all-orthopedic-treatments-and-specialties-at-adia-med</guid>
<pubDate>Mon, 02 Feb 2026 14:00:00 GMT</pubDate>
<description>Winter Park, Florida--(Newsfile Corp. - February 2, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine, stem cell therapies, and premium wellness solutions through its Adia Med division, is pleased to announce that Dr. Brian L. Browning, DO, a board-certified expert in family medicine and neuromusculoskeletal medicine, is now the lead physician in charge of all orthopedic treatments and specialties at Adia Med.Dr. Brian L. BrowningTo view an enhanced version of this...</description>
</item>
<item>
<title>Adia Nutrition Announces Documentary Featuring WWE/TNA Superstar Elias/Elijah Jeff Sciullo's Recovery with Adia Med's AdiaVita Stem Cell Treatment</title>
<link>https://6ix.com/company/adia-nutrition-inc/news/adia-nutrition-announces-documentary-featuring-wwetna-superstar-eliaselijah-jeff-sciullos-recovery-with-adia-meds-adiavita-stem-cell-treatment</link>
<guid isPermaLink="true">https://6ix.com/company/adia-nutrition-inc/news/adia-nutrition-announces-documentary-featuring-wwetna-superstar-eliaselijah-jeff-sciullos-recovery-with-adia-meds-adiavita-stem-cell-treatment</guid>
<pubDate>Wed, 28 Jan 2026 15:00:00 GMT</pubDate>
<description>Winter Park, Florida--(Newsfile Corp. - January 28, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), through its medical division Adia Med specializing in regenerative therapies, is proud to announce an upcoming documentary chronicling the recovery of professional wrestler Jeff Sciullo—known to fans as Elias in WWE and Elijah in TNA—from a tricep injury sustained in June 2025. The film will focus on his treatment with Adia Med's AdiaVita, a high-potency stem cell product delivering over 100 million...</description>
</item>
<item>
<title>Adia Nutrition Announces Every Child in Autism Stem Cell Study Receives Umbilical Cord Blood-Derived Stem Cell Treatments Three Times - Open Nationwide and Worldwide with Participation Cost</title>
<link>https://6ix.com/company/adia-nutrition-inc/news/adia-nutrition-announces-every-child-in-autism-stem-cell-study-receives-umbilical-cord-blood-derived-stem-cell-treatments-three-times-open-nationwide-and-worldwide-with-participation-cost</link>
<guid isPermaLink="true">https://6ix.com/company/adia-nutrition-inc/news/adia-nutrition-announces-every-child-in-autism-stem-cell-study-receives-umbilical-cord-blood-derived-stem-cell-treatments-three-times-open-nationwide-and-worldwide-with-participation-cost</guid>
<pubDate>Mon, 26 Jan 2026 15:00:00 GMT</pubDate>
<description>Winter Park, Florida--(Newsfile Corp. - January 26, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), through its subsidiary Adia Med of Winter Park, LLC, today highlighted key details of its ongoing IRB-approved clinical study for children with Autism Spectrum Disorder (ASD), listed on ClinicalTrials.gov (NCT07304440). The trial ensures every participating child in Phase One or Phase Two receives umbilical cord blood-derived stem cell and exosome treatments (AdiaVita) three times, administered monthly</description>
</item>
<item>
<title>Adia Nutrition Inc. Receives Notification from SEC: Form 10 to Become Effective on February 3, 2026</title>
<link>https://6ix.com/company/adia-nutrition-inc/news/adia-nutrition-inc-receives-notification-from-sec-form-10-to-become-effective-on-february-3-2026</link>
<guid isPermaLink="true">https://6ix.com/company/adia-nutrition-inc/news/adia-nutrition-inc-receives-notification-from-sec-form-10-to-become-effective-on-february-3-2026</guid>
<pubDate>Tue, 20 Jan 2026 14:30:00 GMT</pubDate>
<description>Winter Park, Florida--(Newsfile Corp. - January 20, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine and personalized healthcare, today announced that it has been notified by the U.S. Securities and Exchange Commission (SEC) that its Form 10 registration statement will not be subject to further review. As a result, the Form 10 will automatically become effective 60 days after its original filing date, which is February 3, 2026.The Form 10, originally filed on December</description>
</item>
<item>
<title>Adia Nutrition Promotes Emmanuela Derisbrun, APRN, FNP-C, to Provider Role Amid Growing Patient Demand and Launch of Autism IRB Study</title>
<link>https://6ix.com/company/adia-nutrition-inc/news/adia-nutrition-promotes-emmanuela-derisbrun-aprn-fnp-c-to-provider-role-amid-growing-patient-demand-and-launch-of-autism-irb-study</link>
<guid isPermaLink="true">https://6ix.com/company/adia-nutrition-inc/news/adia-nutrition-promotes-emmanuela-derisbrun-aprn-fnp-c-to-provider-role-amid-growing-patient-demand-and-launch-of-autism-irb-study</guid>
<pubDate>Thu, 15 Jan 2026 16:03:00 GMT</pubDate>
<description>Winter Park, Florida--(Newsfile Corp. - January 15, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), through its medical division Adia Med specializing in advanced regenerative therapies, announces that Emmanuela Derisbrun, APRN, FNP-C, has transitioned from subcontractor to employed provider. This move supports rising patient volume and the launch of Adia Med's IRB-approved autism spectrum disorder regenerative study.Emmanuela Derisbrun, APRN, FNP-CTo view an enhanced version of this graphic, please.</description>
</item>
<item>
<title>Adia Med Kicks Off Recruitment Today for Innovative Autism Stem Cell Study</title>
<link>https://6ix.com/company/adia-nutrition-inc/news/adia-med-kicks-off-recruitment-today-for-innovative-autism-stem-cell-study</link>
<guid isPermaLink="true">https://6ix.com/company/adia-nutrition-inc/news/adia-med-kicks-off-recruitment-today-for-innovative-autism-stem-cell-study</guid>
<pubDate>Tue, 13 Jan 2026 15:16:00 GMT</pubDate>
<description>Winter Park, Florida--(Newsfile Corp. - January 13, 2026) - ADIA Nutrition Inc. (OTCQB: ADIA), today announced that its subsidiary, Adia Med of Winter Park, LLC., has officially begun the recruitment process for a groundbreaking clinical study evaluating the potential benefits of stem cell therapy in children with Autism Spectrum Disorder (ASD). The 24-month randomized interventional study, officially titled "Adia MED of Winter Park LLC Autism Spectrum Disorder Research Study" and listed on...</description>
</item>
<item>
<title>ADIA Nutrition Appoints Dawn Bell as Chief Revenue Officer to Accelerate Growth and Drive Success Across Physician Network</title>
<link>https://6ix.com/company/adia-nutrition-inc/news/adia-nutrition-appoints-dawn-bell-as-chief-revenue-officer-to-accelerate-growth-and-drive-success-across-physician-network</link>
<guid isPermaLink="true">https://6ix.com/company/adia-nutrition-inc/news/adia-nutrition-appoints-dawn-bell-as-chief-revenue-officer-to-accelerate-growth-and-drive-success-across-physician-network</guid>
<pubDate>Thu, 08 Jan 2026 13:30:00 GMT</pubDate>
<description>Winter Park, Florida--(Newsfile Corp. - January 8, 2026) - ADIA Nutrition, Inc. (OTCQB: ADIA), a rapidly growing leader in regenerative medicine, today announced the appointment of Dawn Bell as Chief Revenue Officer (CRO) through its subsidiary, ADIA Labs. Ms. Bell brings more than 15 years of proven expertise as a sales strategist in the medical device and pharmaceutical industries, with a strong history of driving growth and building successful partnerships.Dawn BellTo view an enhanced version</description>
</item>
<item>
<title>Adia Nutrition Inc. Announces Landmark Autism Spectrum Disorder Clinical Study Now Live on ClinicalTrials.gov</title>
<link>https://6ix.com/company/adia-nutrition-inc/news/adia-nutrition-inc-announces-landmark-autism-spectrum-disorder-clinical-study-now-live-on-clinicaltrialsgov</link>
<guid isPermaLink="true">https://6ix.com/company/adia-nutrition-inc/news/adia-nutrition-inc-announces-landmark-autism-spectrum-disorder-clinical-study-now-live-on-clinicaltrialsgov</guid>
<pubDate>Mon, 05 Jan 2026 15:21:00 GMT</pubDate>
<description>Winter Park, Florida--(Newsfile Corp. - January 5, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), an emerging leader in regenerative medicine through its subsidiary Adia Med, today announced that its patent-pending clinical study targeting Autism Spectrum Disorder (ASD) has gone live on ClinicalTrials.gov, marking a significant advancement in the company's research pipeline.Clinical trial NCT07304440To view an enhanced version of this graphic, please...</description>
</item>
</channel>
</rss>